Summary & Overview
CPT 0627T: Lumbar Intradiscal Cellular/Tissue Injection under Fluoroscopy
CPT code 0627T defines an image-guided intradiscal procedure in which a cellular or tissue–based product is injected into a lumbar intervertebral disc under fluoroscopic guidance. This code covers the first lumbar level treated and can represent a unilateral or bilateral injection. The code is notable nationally as regenerative and biologic intradiscal therapies expand and attract payer attention for coverage policy, coding guidance, and utilization oversight.
Key payers in the national analysis include Aetna, Blue Cross Blue Shield plans, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical procedure context, common billing considerations, and payer coverage framing. The publication summarizes available benchmarks where present, highlights relevant policy and coding updates impacting reimbursement and prior authorization, and situates 0627T within outpatient interventional spine service lines.
This summary is intended to inform billing managers, coding professionals, and policy analysts about the clinical purpose of the code, typical sites of service, and the payer landscape. Data not available in the input is noted where applicable in subsequent sections.
Billing Code Overview
CPT code 0627T describes the injection of a cellular or tissue–based product under fluoroscopic guidance into a lumbar intervertebral disc. The code applies to the first lumbar level treated; the injection may be performed on one side or both.
-
Service type: Image-guided intradiscal biologic injection
-
Typical site of service: Outpatient procedure suite or ambulatory surgery center with fluoroscopic imaging capability
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient with chronic axial low back pain and imaging-confirmed single-level lumbar disc degeneration (posterior L5–S1 disc dessiccation and focal annular tear) who has failed conservative care including physical therapy, activity modification, oral analgesics, and at least one epidural steroid injection undergoes injection of a cellular or tissue–based product into the affected lumbar intervertebral disc under fluoroscopic guidance. The procedure is performed in an outpatient ambulatory surgery center or hospital interventional radiology suite with conscious sedation or monitored anesthesia care. The patient is positioned prone, sterile technique is used, and fluoroscopy localizes the target disc. A spinal needle is advanced into the nucleus pulposus; the investigational or biologic product is injected into the disc space for the first treated level. Post-procedure fluoroscopic images confirm placement and absence of extravasation. The patient is observed in recovery for immediate complications and discharged with activity restrictions and follow-up instructions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or complexity is substantially greater than typical for 0627T and documentation supports unusual effort. |